ertugliflozin and metformin (Segluromet) Last Updated: August 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: ertugliflozin and metformin hydrochloride Indications: Diabetes mellitus, Type 2 Brand Name: SeglurometManufacturer: Merck Canada Inc.Project Number: SR0566-000 Project Status: ActiveSubmission Type: NewCombination Tags Diabetes Mellitus, Diabetes, segluromet; ertugliflozin; metformin; Diabetes; Diabetic Details
cerliponase alfa (Brineura) Last Updated: August 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: cerliponase alfa Indications: Neuronal Ceroid Lipofuscinosis Type 2 Brand Name: BrineuraManufacturer: Biomarin Pharmaceutical (Canada) Inc.Project Number: SR0574-000Project Status: ActiveSubmission Type: New Tags Genetics, Nervous System, Genetics, Nervous system Details
eluxadoline (Viberzi) Last Updated: August 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: eluxadoline Indications: Irritable bowel syndrome with diarrhea Brand Name: ViberziManufacturer: Allergan Pharma Co.Project Number: SR0560-000Project Status: ActiveSubmission Type: New Tags Digestive System, Gastrointestinal Tract, Diarrhea, Irritable Bowel Syndrome, Digestive system, Gastrointestinal tract, irritable bowel; Diarrhea Details
fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) Last Updated: August 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: fluticasone furoate umeclidinium vilanterol Indications: Chronic obstructive pulmonary disease (COPD) Brand Name: Trelegy ElliptaManufacturer: GlaxoSmithKline Inc.Project Number: SR0562-000Project Status: ActiveSubmission Type: NewCombination Tags COPD, Pulmonary Disease, Chronic Obstructive, COPD, Respiratory, COPD; emphysema Details
ertugliflozin (Steglatro) Last Updated: August 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: ertugliflozin Indications: Diabetes mellitus, Type 2 Brand Name: SteglatroManufacturer: Merck Canada Inc.Project Number: SR0565-000Project Status: ActiveSubmission Type: New Tags Diabetes Mellitus, Diabetes, steglatro; ertugliflozin; Diabetes; Diabetic Details
buprenorphine hydrochloride (Probuphine) Last Updated: August 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: buprenorphine hydrochloride Indications: Opioid drug dependence, treatment Brand Name: ProbuphineManufacturer: Knight Therapeutics Inc.Project Number: SR0550-000Project Status: ActiveSubmission Type: New Tags Mental Health, Drug Implants, Opioid-Related Disorders, Addiction, Mental health, Probuphine; buprenorphine hydrochloride Details
sebelipase alfa (Kanuma) Last Updated: August 16, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: sebelipase alfa Indications: Lysosomal acid lipase deficiency Brand Name: KanumaManufacturer: Alexion PharmaceuticalsProject Number: SR0544-000Project Status: ActiveSubmission Type: New Tags Genetics, Pediatrics, Cholesterol Ester Storage Disease, Dyslipidemias, Wolman Disease, Genetics, Pediatrics, sebelipase alfa; lysosomal disorder Details
Gazyva for Follicular Lymphoma (previously untreated) – Details Published on: August 17, 2018 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10126 Tags Cancer, Lymphoma Details
Opdivo in combo with Yervoy for Renal Cell Carcinoma – Details Published on: August 17, 2018 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10132
Apalutamide for Castrate Resistant Prostate Cancer - Details Published on: August 17, 2018 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10133 Tags Cancer, Prostate cancer Details
